Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Exelixis
Company Monitoring Page for Exelixis
latest headlines for company on cafepharma
JPMorgan Healthcare Conference Highlights: Exelixis
Motley Fool
Mon, 01/14/13 - 12:30 pm
Tags:
Exelixis
,
JPMHC 2013
,
Cometriq
,
medullary thyroid cancer
3 Biotech Stocks You Can Buy in 2013
Motley Fool
Fri, 01/4/13 - 11:16 am
Tags:
Gilead
,
Exelixis
,
Dendreon
Biotech Portfolio Update: 2012 Summary And 2013 Outlook
Seeking Alpha
Mon, 12/24/12 - 10:44 am
Tags:
Arqule
,
Array Biopharma
,
Celldex
,
Aveo Pharmaceutical
,
Curis
,
Exelixis
,
MorphoSys
,
Genmab
,
Novartis
,
Incyte
,
Seattle Genetics
,
YM BioSciences
Aveo Pharmaceuticals: A Hidden Gem Or A Hidden Disaster
Seeking Alpha
Mon, 12/10/12 - 12:30 pm
Tags:
Aveo Pharmaceutical
,
tivozanib
,
Pfizer
,
ONYX Pharmaceuticals
,
Novartis
,
GSK
,
Eli Lilly
,
Exelixis
The Worst-Performing Biotechs in 2012 and 1 to Avoid in 2013
Motley Fool
Sun, 12/9/12 - 01:21 pm
Tags:
Chelsea Therapeutics
,
Cell Therapeutics
,
Aeterna Zentaris
,
Progenics Pharmaceuticals
,
Aveo Pharmaceutical
,
Exelixis
The Road Toward Far-Reaching Therapeutics Through Illumina, Sarepta
Seeking Alpha
Tue, 12/4/12 - 01:36 pm
Tags:
Sarepta
,
Illumina
,
Life Technologies
,
Exelixis
Exelixis' Crowning Achievement
Motley Fool
Sat, 12/1/12 - 09:26 am
Tags:
Exelixis
,
cabozantinib
,
Cometriq
,
thyroid cancer
,
medullary thyroid cancer
Exelixis Wins First Approval of Cancer Drug
Minyanville
Fri, 11/30/12 - 09:37 am
Tags:
medullary thyroid cancer
,
Exelixis
,
Cometriq
Exelixis Traders Brace For Upcoming FDA Decision
Seeking Alpha
Tue, 11/27/12 - 11:10 am
Tags:
FDA
,
Exelixis
,
medullary thyroid cancer
,
cabozantinib
Exelixis's Cabozantinib Should Receive FDA Approval, But Faces Long-Term Challenges
Seeking Alpha
Mon, 11/26/12 - 10:55 am
Tags:
cabozantinib
,
FDA
,
Exelixis
,
medullary thyroid cancer
Exelixis, Celgene, Gilead Sciences, Dynavax See Key Dates in November
Minyanville
Wed, 10/31/12 - 11:52 am
Tags:
Exelixis
,
Celgene
,
Gilead
,
Dynavax
ArQule's Tivantinib Failure And Exelixis' Cabozantinib PDUFA: Is There A Correlation?
Seeking Alpha
Fri, 10/12/12 - 12:17 pm
Tags:
Arqule
,
tivantinib
,
Exelixis
,
cabozantinib
,
non-small cell lung cancer
Exelixis: First Partnered Program Enters Phase III
Seeking Alpha
Wed, 10/3/12 - 11:20 am
Tags:
Exelixis
,
Roche
,
GSK
,
GDC-0973
,
MEK inhibitor
,
melanoma
Preliminary Phase 1 Data for Cabozantinib in Japanese Patients Presented at ESMO 2012
Yahoo/BusinessWire
Sun, 09/30/12 - 10:31 am
Tags:
cabozantinib
,
Exelixis
,
solid tumors
Exelixis Announces Data Presentation for GDC-0973 (XL518)
Yahoo/BusinessWire
Sat, 09/29/12 - 11:59 am
Tags:
Exelixis
,
GDC-0973
,
XL518
,
melanoma
Exelixis Provides Update on ODAC Panel for Cabozantinib
Yahoo
Thu, 08/30/12 - 09:46 am
Tags:
Exelixis
,
cabozantinib
,
medullary thyroid cancer
Upcoming Catalysts For Exelixis And Immunogen
Seeking Alpha
Mon, 08/27/12 - 10:32 am
Tags:
Exelixis
,
Immunogen
,
prostate cancer
,
breast cancer
Maxim Group Highlights 3 Biotech Stocks With Key Milestones Ahead
Seeking Alpha
Sat, 08/25/12 - 11:35 am
Tags:
Ariad
,
Exelixis
,
Medgenics
4 Small-Cap Biotech Stocks Generating Profits With Buy Ratings
Seeking Alpha
Sat, 08/4/12 - 11:30 am
Tags:
Exelixis
,
Spectrum Pharmaceuticals
,
ViroPharma
,
Momenta
FDA Grants Priority Review for Cabozantinib in Medullary Thyroid Cancer
Yahoo
Mon, 07/30/12 - 11:00 am
Tags:
FDA
,
cabozantinib
,
medullary thyroid cancer
,
Exelixis
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.